BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17123862)

  • 1. Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acid.
    Uchiyama A; Mukai M; Fujiwara Y; Kobayashi S; Kawai N; Murofushi H; Inoue M; Enoki S; Tanaka Y; Niki T; Kobayashi T; Tigyi G; Murakami-Murofushi K
    Biochim Biophys Acta; 2007 Jan; 1771(1):103-12. PubMed ID: 17123862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic phosphatidic acid inhibits RhoA-mediated autophosphorylation of FAK at Tyr-397 and subsequent tumor-cell invasion.
    Mukai M; Iwasaki T; Tatsuta M; Togawa A; Nakamura H; Murakami-Murofushi K; Kobayashi S; Imamura F; Inoue M
    Int J Oncol; 2003 Jun; 22(6):1247-56. PubMed ID: 12738990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis.
    Baker DL; Fujiwara Y; Pigg KR; Tsukahara R; Kobayashi S; Murofushi H; Uchiyama A; Murakami-Murofushi K; Koh E; Bandle RW; Byun HS; Bittman R; Fan D; Murph M; Mills GB; Tigyi G
    J Biol Chem; 2006 Aug; 281(32):22786-93. PubMed ID: 16782709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclic phosphatidic acids and their analogues--unique lipid mediators].
    Grzelczyk A; Koziołkiewicz M
    Postepy Biochem; 2012; 58(3):327-43. PubMed ID: 23373418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic phosphatidic acid and lysophosphatidic acid induce hyaluronic acid synthesis via CREB transcription factor regulation in human skin fibroblasts.
    Maeda-Sano K; Gotoh M; Morohoshi T; Someya T; Murofushi H; Murakami-Murofushi K
    Biochim Biophys Acta; 2014 Sep; 1841(9):1256-63. PubMed ID: 24845645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of enantiopure 2-carba-cyclic phosphatidic acid and effects of its chirality on biological functions.
    Nozaki E; Gotoh M; Hotta H; Hanazawa S; Kobayashi S; Murakami-Murofushi K
    Biochim Biophys Acta; 2011 Apr; 1811(4):271-7. PubMed ID: 21277386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA).
    Mukai M; Imamura F; Ayaki M; Shinkai K; Iwasaki T; Murakami-Murofushi K; Murofushi H; Kobayashi S; Yamamoto T; Nakamura H; Akedo H
    Int J Cancer; 1999 Jun; 81(6):918-22. PubMed ID: 10362139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acid.
    Gupte R; Siddam A; Lu Y; Li W; Fujiwara Y; Panupinthu N; Pham TC; Baker DL; Parrill AL; Gotoh M; Murakami-Murofushi K; Kobayashi S; Mills GB; Tigyi G; Miller DD
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7525-8. PubMed ID: 21051230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alkyl lysophosphatidic acid and fluoromethylene phosphonate analogs as metabolically-stabilized agonists for LPA receptors.
    Xu Y; Tanaka M; Arai H; Aoki J; Prestwich GD
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5323-8. PubMed ID: 15454220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological evaluation of a novel cyclic phosphatidic acid derivative 3-S-cyclic phosphatidic acid (3-S-cPA).
    Nozaki E; Gotoh M; Tanaka R; Kato M; Suzuki T; Nakazaki A; Hotta H; Kobayashi S; Murakami-Murofushi K
    Bioorg Med Chem; 2012 May; 20(10):3196-201. PubMed ID: 22512905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of cyclic phosphatidic acid-induced lymphangiogenic actions in vitro.
    Okuyama K; Mizuno K; Nittami K; Sakaue H; Sato T
    Microvasc Res; 2022 Jan; 139():104273. PubMed ID: 34699844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoma cell migration through a mesothelial cell monolayer is inhibited by cyclic AMP-elevating agents via a Rho-dependent pathway.
    Mukai M; Nakamura H; Tatsuta M; Iwasaki T; Togawa A; Imamura F; Akedo H
    FEBS Lett; 2000 Nov; 484(2):69-73. PubMed ID: 11068034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition.
    Fukasawa K; Gotoh M; Uwamizu A; Hirokawa T; Ishikawa M; Shimizu Y; Yamamoto S; Iwasa K; Yoshikawa K; Aoki J; Murakami-Murofushi K
    Sci Rep; 2021 Aug; 11(1):17360. PubMed ID: 34462512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of migration-resistant hydroxyethoxy analogues of lysophosphatidic acid.
    Qian L; Xu Y; Arai H; Aoki J; McIntyre TM; Prestwich GD
    Org Lett; 2003 Nov; 5(24):4685-8. PubMed ID: 14627415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive effect of cyclic phosphatidic acid and its derivative on animal models of acute and chronic pain.
    Kakiuchi Y; Nagai J; Gotoh M; Hotta H; Murofushi H; Ogawa T; Ueda H; Murakami-Murofushi K
    Mol Pain; 2011 May; 7():33. PubMed ID: 21569544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
    Gueguen G; Gaigé B; Grévy JM; Rogalle P; Bellan J; Wilson M; Klaébé A; Pont F; Simon MF; Chap H
    Biochemistry; 1999 Jun; 38(26):8440-50. PubMed ID: 10387090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-O-Carba-oleoyl cyclic phosphatidic acid induces glial proliferation through the activation of lysophosphatidic acid receptor.
    Nakajima S; Gotoh M; Fukasawa K; Murofushi H; Murakami-Murofushi K
    Brain Res; 2018 Feb; 1681():44-51. PubMed ID: 29278716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic phosphatidic acid decreases proliferation and survival of colon cancer cells by inhibiting peroxisome proliferator-activated receptor γ.
    Tsukahara T; Hanazawa S; Kobayashi T; Iwamoto Y; Murakami-Murofushi K
    Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):126-33. PubMed ID: 20932931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic phosphatidic acid - a unique bioactive phospholipid.
    Fujiwara Y
    Biochim Biophys Acta; 2008 Sep; 1781(9):519-24. PubMed ID: 18554524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activity.
    Qian L; Xu Y; Hasegawa Y; Aoki J; Mills GB; Prestwich GD
    J Med Chem; 2003 Dec; 46(26):5575-8. PubMed ID: 14667211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.